<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>LAC HYDRIN CREAM- ammonium lactate cream </strong><br>Ranbaxy Laboratories Inc.<br></p></div>
<h1>Rx only<br>Lac-Hydrin® 12%*<br>(ammonium lactate) Cream<br>For Dermatologic use only. Not for Ophthalmic, Oral or Intravaginal use.</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="inv-98dc18ba-36ef-4433-b974-f22158a30962"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First"><a name="inv-8153f4f7-a6da-402b-b121-8f947aed49f0"></a><span class="Sup">*</span>Lac-Hydrin is a formulation of 12% lactic acid neutralized with ammonium hydroxide, as ammonium lactate with a pH of 4.4-5.4. Lac-Hydrin<span class="Sup">®</span> 12% (ammonium lactate) Cream also contains cetyl alcohol, glycerin, glyceryl stearate, laureth-4, light mineral oil, magnesium aluminum silicate, methylcellulose, methyl and propyl parabens, PEG-100 stearate, polyoxyl 40 stearate, propylene glycol and water. Lactic acid is a racemic mixture of 2-hydroxypropanoic acid and has the following structural formula:</p>
<div class="Figure">
<a name="ID0EFBAC"></a><img alt="This is the structural formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=807054c6-2dae-4cc2-b790-674ab66cf79b&amp;name=structure.jpg">
</div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="inv-de1abbd7-a4a6-40e3-8136-9744b0e8100b"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First"><a name="inv-c063eac7-8a05-4384-9a9c-bae99df2dd4d"></a>Lactic acid is an alpha-hydroxy acid. It is a normal constituent of tissues and blood. The alpha-hydroxy acids (and their salts) are felt to act as humectants when applied to the skin. This property may influence hydration of the stratum corneum. In addition, lactic acid, when applied to the skin, may act to decrease corneocyte cohesion. The mechanism(s) by which this is accomplished is not yet known.</p>
<p><a name="inv-fa123ec9-ec7b-4e91-a12e-81b62eeb36f6"></a>An <span class="Italics">in vitro </span>study of percutaneous absorption of Lac-Hydrin Cream using human cadaver skin indicates that approximately 6.1% of the material was absorbed after 68 hours.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="inv-32a8cefd-6c67-4cd6-9f35-39103b6c2afd"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First"><a name="inv-dda616c4-629c-454f-b055-d43274e30c34"></a>Lac-Hydrin Cream is indicated for the treatment of <span class="product-label-link" type="condition" conceptid="134743" conceptname="Congenital ichthyosis of skin">ichthyosis</span> vulgaris and xerosis.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="inv-c354f9b7-1e31-449d-8cda-132d5cc70c52"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><a name="inv-f92ced53-9946-4c05-b118-15b0b0613633"></a>Lac-Hydrin Cream is contraindicated in those patients with a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the label ingredients.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="inv-60cc5594-c524-436e-8d46-13b6d4fe8e5a"></a><a name="section-5"></a><p></p>
<h1>WARNING</h1>
<p class="First"><a name="inv-d4d58086-a2ee-4a59-a5c0-cb7a6bbe4c00"></a>Sun exposure to areas of the skin treated with Lac-Hydrin Cream should be minimized or avoided (see <span class="Bold">PRECAUTIONS </span>section).The use of Lac-Hydrin Cream should be discontinued if any <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> is observed.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="inv-c0edb135-0b4d-4e9a-a281-07c583202d1a"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="inv-52941b20-3a89-43da-8662-12312a38476f"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First"><a name="inv-ce5954cb-85ba-4764-bf87-6a634ea1bdcf"></a>For external use only. <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Stinging</span> or burning may occur when applied to skin with fissures, erosions, or that is otherwise abraded (for example, after shaving the legs).Caution is advised when used on the face because of the potential for irritation. The potential for post-inflammatory hypo- or hyperpigmentation has not been studied.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="inv-94d4931e-9975-4756-bda3-a20b3ff01ba1"></a><a name="section-6.2"></a><p></p>
<h2>Information For Patients</h2>
<p class="First"><a name="inv-79a3dd3e-5dd8-44f4-926c-117193a5c53c"></a>Patients using Lac-Hydrin Cream should receive the following information and instructions:</p>
<ol class="Arabic">
<li>This medication is to be used as directed by the physician, and should not be used for any disorder other than for which it was prescribed. It is for external use only. Avoid contact with eyes, lips, or mucous membranes.</li>
<li>Patients should minimize or avoid use of this product on areas of the skin that may be exposed to natural or artificial sunlight, including the face. If sun exposure isunavoidable, clothing should be worn to protect the skin.</li>
<li>This medication may cause <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span> or burning when applied to skin with fissures, erosions, or <span class="product-label-link" type="condition" conceptid="4269361" conceptname="Friction burn">abrasions</span> (for example, after shaving the legs).</li>
<li>If the skin condition worsens with treatment, the medication should be promptly discontinued.</li>
</ol>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="inv-ac06c032-5db8-42f8-b53f-307125ea1883"></a><a name="section-6.3"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First"><a name="inv-cfbe4ff2-578b-4abf-b80e-8e33c6522f17"></a>The topical treatment of CD-1 mice with 12%, 21% or 30% ammonium lactate formulations for two years did not produce a significant increase in dermal or systemic tumors in the absence of increased exposure to ultraviolet radiation. The maximum systemic exposure of the mice in this study was 0.7 times the maximum possible systemic exposure in humans. However, a long-term photocarcinogenicity study in hairless albino mice suggested that topically applied 12% ammonium lactate cream enhanced the rate of ultraviolet light-induced <span class="product-label-link" type="condition" conceptid="135777" conceptname="Neoplasm of uncertain behavior of skin">skin tumor</span> formation.</p>
<p><a name="inv-06ea6cff-f2ef-4e19-b136-e38e83558c9f"></a>The mutagenic potential of ammonium lactate cream was evaluated in the Ames assay and in the mouse <span class="Italics">in vivo </span>micronucleus assay, both of which were negative.</p>
<p><a name="inv-b5cf0633-d321-49ba-b684-31d322d3f47e"></a>In dermal Segment I and III studies with ammonium lactate cream there were no effects observed in fertility or pre- or post-natal development parameters in rats at dose levels of 300 mg/kg/day (1800 mg/m<span class="Sup">2</span>/day), approximately 0.4 times the human topical dose.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="inv-527746a1-3f2e-4b7c-9a25-ce857a962a3e"></a><a name="section-6.4"></a><p></p>
<h2>Pregnancy</h2>
<p class="First"><a name="inv-440d7d52-ae94-445d-9b62-e80eb1034576"></a><span class="Bold">Teratogenic effects: Pregnancy Category B.</span></p>
<p><a name="inv-7a29ef0d-8373-400e-a741-686f3e64bd06"></a>Animal reproduction studies have been performed in rats and rabbits at doses up to 0.7 and 1.5 times the human dose, respectively (600 mg/kg/day, corresponding to 3600 mg/m<span class="Sup">2</span>/day in the rat and 7200 mg/m<span class="Sup">2</span>/day in the rabbit) and have revealed no evidence of impaired fertility or harm to the fetus due to ammonium lactate cream. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Lac-Hydrin Cream should be used during pregnancy only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="inv-7d019db3-eb1b-40ca-a37d-fd147575c884"></a><a name="section-6.5"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First"><a name="inv-73437812-0aa3-4d03-a006-83f9c72174eb"></a>Although lactic acid is a normal constituent of blood and tissues, it is not known to what extent this drug affects normal lactic acid levels in human milk. Because many drugs are excreted in human milk, caution should be exercised when Lac-Hydrin is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="inv-92ead30c-b7cb-4d5b-8e87-212ebd368bd2"></a><a name="section-6.6"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First"><a name="inv-fb772de3-9c97-4b53-823e-0de31daf8425"></a>The safety and effectiveness of Lac-Hydrin Cream have been established in pediatric patients as young as 2 years old.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="inv-f22cb664-84d3-408c-8764-9f495e364ace"></a><a name="section-6.7"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First"><a name="inv-89559b2c-93be-46d0-951e-1fde8131cdee"></a>Clinical studies of Lac-Hydrin<span class="Sup">®</span> (ammonium lactate) Cream, 12% did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients. In general, dose selection for an elderly patient should be cautious.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="inv-0f4cca0d-1cc5-4d68-aaf2-0136d8f60fac"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><a name="inv-cb898b6b-d6a5-4a8c-b862-4d5ea19ff9a6"></a>In controlled clinical trials of patients with <span class="product-label-link" type="condition" conceptid="134743" conceptname="Congenital ichthyosis of skin">ichthyosis</span> vulgaris, the most frequent adverse reactions in patients treated with Lac-Hydrin Cream were <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span> (including <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> and irritation) and burning/<span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>. Each was reported in approximately 10-15% of patients. In addition, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span> was reported in approximately 5% of patients.</p>
<p><a name="inv-a7a6b40b-12f6-4e02-9848-07fdf3a8b025"></a>In controlled clinical trials of patients with xerosis, the most frequent adverse reactions in patients treated with Lac-Hydrin Cream were transient burning, in about 3% of patients, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>, <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">dry skin</span> and <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, each reported in approximately 2% of patients.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="inv-ded5834a-274c-42a9-a357-2a3e8bcf72ff"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First"><a name="inv-4cbf8daa-016e-4a4e-ab83-5053ab26657d"></a>Apply to the affected areas and rub in thoroughly. Use twice daily or as directed by a physician.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="inv-d8d37ae6-9f70-4932-95e0-1dc6a56cb625"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First"><a name="inv-e7e6d6af-107c-491a-a949-63fd4cff091a"></a>Lac-Hydrin<span class="Sup">®</span> 12%<span class="Sup">*</span> (ammonium lactate) Cream is available in cartons of 280 g (two 140 g plastic tubes) (NDC # 10631-099-28) and 385 g plastic bottle (NDC # 10631-099-38). Store at controlled room temperature, 15<span class="Sup">°</span> C-30<span class="Sup">°</span> C (59<span class="Sup">°</span> F-86<span class="Sup">° </span>F).</p>
<p><a name="inv-8f9e7189-6133-40ed-b230-3eda490f6c0f"></a><span class="Bold">RANBAXY</span></p>
<p><a name="inv-2d8a0673-a208-4672-a19d-e036d141b241"></a>Jacksonville, FL 32257 USA</p>
<p><a name="inv-6bc307a5-ab16-4cd2-980f-3a7136f46827"></a>Revised July 2009</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="inv-a7d1dce6-cc5b-4302-ad92-6970b09ae8a0"></a><a name="section-10"></a><p></p>
<h1>PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.</h1>
<div class="Figure">
<a name="ID0EULAC"></a><img alt="This is the 140 gram tube label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=807054c6-2dae-4cc2-b790-674ab66cf79b&amp;name=contain140g.jpg"><p class="MultiMediaCaption">140 gram tube</p>
</div>
<div class="Figure">
<a name="ID0E3LAC"></a><img alt="This is the 280 gram carton label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=807054c6-2dae-4cc2-b790-674ab66cf79b&amp;name=carton140g.jpg"><p class="MultiMediaCaption">280 gram carton</p>
</div>
<div class="Figure">
<a name="ID0EEMAC"></a><img alt="This is the 385 gram bottle label-Front" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=807054c6-2dae-4cc2-b790-674ab66cf79b&amp;name=contain385g_1.jpg"><p class="MultiMediaCaption">385 gram Bottle ECL (front)</p>
</div>
<div class="Figure">
<a name="ID0EMMAC"></a><img alt="This is the 385 gram bottle label-Back" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=807054c6-2dae-4cc2-b790-674ab66cf79b&amp;name=contain385g_2.jpg"><p class="MultiMediaCaption">385 gram Bottle ECL (back)</p>
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>LAC HYDRIN 		
					CREAM</strong><br><span class="contentTableReg">ammonium lactate cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:10631-099</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>AMMONIUM LACTATE</strong> (LACTIC ACID) </td>
<td class="formItem">AMMONIUM LACTATE</td>
<td class="formItem">120 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CETYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>GLYCERIN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LIGHT MINERAL OIL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM ALUMINUM SILICATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>METHYLPARABEN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PROPYLPARABEN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYOXYL 40 STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LAURETH-4</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:10631-099-28</td>
<td class="formItem">140 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:10631-099-38</td>
<td class="formItem">385 g in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA020508</td>
<td class="formItem">03/16/2009</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Ranbaxy Laboratories Inc.
							(169932519)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Ranbaxy Laboratories Inc. (169932519)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Contract Pharmaceuticals Limited</td>
<td class="formItem"></td>
<td class="formItem">248761249</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 9/2009<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>807054c6-2dae-4cc2-b790-674ab66cf79b</div>
<div>Set id: 807054c6-2dae-4cc2-b790-674ab66cf79b</div>
<div>Version: 1</div>
<div>Effective Time: 20090925</div>
</div>
</div> <div class="DistributorName">Ranbaxy Laboratories Inc.</div></p>
</body></html>
